Compare DSWL & DRIO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | DSWL | DRIO |
|---|---|---|
| Founded | 1987 | 2011 |
| Country | Macau | United States |
| Employees | N/A | N/A |
| Industry | Plastic Products | Medical/Dental Instruments |
| Sector | Industrials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 58.9M | 60.6M |
| IPO Year | 2000 | 2013 |
| Metric | DSWL | DRIO |
|---|---|---|
| Price | $3.77 | $7.03 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 2 |
| Target Price | N/A | ★ $35.00 |
| AVG Volume (30 Days) | ★ 10.7K | 7.1K |
| Earning Date | 06-17-2026 | 05-14-2026 |
| Dividend Yield | ★ 5.90% | N/A |
| EPS Growth | N/A | ★ 1559.02 |
| EPS | N/A | ★ 1.25 |
| Revenue | N/A | ★ $7,394,000.00 |
| Revenue This Year | N/A | $20.27 |
| Revenue Next Year | N/A | $47.58 |
| P/E Ratio | ★ $4.59 | $4.92 |
| Revenue Growth | N/A | ★ 43.02 |
| 52 Week Low | $2.55 | $0.38 |
| 52 Week High | $4.48 | $17.74 |
| Indicator | DSWL | DRIO |
|---|---|---|
| Relative Strength Index (RSI) | 64.16 | 45.88 |
| Support Level | $3.23 | $6.16 |
| Resistance Level | $4.06 | $9.46 |
| Average True Range (ATR) | 0.11 | 0.47 |
| MACD | 0.05 | -0.07 |
| Stochastic Oscillator | 82.09 | 56.35 |
Deswell Industries Inc is engaged in the manufacturing and selling of injection-molded plastic parts and components. In addition, it also offers manufacturing services for electronic products and subassemblies and manufactures metallic molds and accessory parts for original equipment manufacturers and contract manufacturers. The company conducts all of its manufacturing activities at separate plastics, electronics and metallic operation factories located in the People's Republic of China. It operates through the Plastic Injection Molding and Electronic Products Assembling segments. The firm offers products such as automobile components, medical testing equipment, parts for audio equipment, av receivers, active subwoofers, digital system key sets, communication products and others.
DarioHealth Corp is a digital therapeutics (DTx) company delivering personalized evidence-based interventions that are driven by precision data analytics, software, and personalized coaching. The company vertically integrated a health intelligence platform with a mission to power the behavior changes that drive greater health. Unlike software-only digital health platforms, Dario owns the complete chain of value in chronic care management - connected FDA-cleared hardware devices that generate continuous physiological data, and AI built on that proprietary data. The company focuses on delivering user experiences, longer sustained engagement, and stronger clinical outcomes, at affordable prices, which then delivers the highest return on investment in the industry.